In a strategic move to enhance its manufacturing capabilities, Merck has inaugurated a new $1 billion vaccine manufacturing facility in Durham, North Carolina. This facility is part of Merck’s ...

In another development, Merck has opened a $1 billion vaccine manufacturing facility in Durham, North Carolina, to strengthen its U.S. manufacturing capabilities. The facility incorporates ...

💊𝗕𝗹𝗼𝗴𝗴𝗲𝗿 #ConnectingInforming #DrugDiscoverytoDrugDelivery 💻𝗩𝗶𝗱𝗲𝗼 𝗖𝗼𝗻𝘁𝗲𝗻𝘁 𝗖𝗿𝗲𝗮𝘁𝗼𝗿 YouTube: RSK Life Science ...

Merck & Co. (MRK) releases positive phase three data for its injectable-form cancer drug Keytruda. Yahoo Finance Senior Health Reporter Anjalee Khemlani joins Market Domination to break down the ...

The decision was based on the lack of substantial evidence to support the claims. In another development, Merck has opened a $1 billion vaccine manufacturing facility in Durham, North Carolina, to ...

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The company offers human health pharmaceutical for various areas ...

MSD has entered an exclusive licence agreement with Hengrui Pharma for the oral small molecule Lp(a) inhibitor, HRS-5346.

In October, Merck took up an option on the personalised RNA-based cancer vaccine with an upfront payment of $250 million as part of a collaboration first agreed in 2016 and expanded in 2018.

During an R&D update yesterday Merck said it is hoping to claim eight new cardiovascular therapy approvals between now and 2030, for diseases like atherosclerosis, heart failure, pulmonary ...

“It is more critical than ever that we are actively working to support, not stifle, our labor unions,” says one DPS school board member. Real-time updates and all local stories you want right ...